PDZK1, a direct target of Gli2, promotes FGFR3 trafficking and cell proliferation in colorectal cancer
Cellular Signalling · 2025
DOI: 10.1016/j.cellsig.2025.112175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2025. Verfasst von Hui Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Experimental Medicine; The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, The First Affiliated Ho…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Receptor, Fibroblast Growth Factor, Type 3, Zinc Finger Protein Gli2, Carrier Proteins. Die Arbeit nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangxi Provincial Natural Science Foundation, Nanchang University.
Abstract (Originalsprache)
In colorectal cancer (CRC), dysregulated Hedgehog (Hh) and fibroblast growth factor receptor 3 (FGFR3)-related pathways drive tumor progression, but their molecular crosstalk remains poorly understood. Here, we demonstrate that the scaffold protein PDZ domain-containing1 (PDZK1) is significantly upregulated in CRC and associated with poor patient prognosis. Functionally, PDZK1 promotes CRC cell proliferation by serving as a direct transcriptional target of Gli family zinc finger 2 (Gli2), the key effector of Hh signaling. Knockdown of PDZK1 markedly attenuated Gli2-driven oncogenic effects, whereas enforced PDZK1 expression rescued the growth inhibition induced by Gli2 silencing, confirming its essential role in Hh signaling-mediated malignancy. Mechanistically, PDZK1 physically interacts with FGFR3 and facilitates its membrane trafficking, thereby enhancing receptor availability and downstream activation of AKT and STAT3 signaling. Our findings reveal PDZK1 as a critical oncogenic scaffold bridging Hh and FGFR3-related pathways in CRC, offering a potential therapeutic target for intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Experimental Medicine; The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China;…
- Department of Biostatistics and Epidemiology, School of Public Health, Jiangxi Medical College; Jiangxi Provincial Key Laboratory of Disease Prevention and Public Health, Nanchang University, Nanchang, China.
Förderung
- National Natural Science Foundation of China
- Jiangxi Provincial Natural Science Foundation
- Nanchang University
- Key Research and Development Program of Jiangxi Province
Zitieren
APA
Wang, H., Li, D., Yu, Z., Zhang, J., Luo, S., & Zhang, Y. (2025). PDZK1, a direct target of Gli2, promotes FGFR3 trafficking and cell proliferation in colorectal cancer. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2025.112175
Vancouver
Wang H, Li D, Yu Z, Zhang J, Luo S, Zhang Y. PDZK1, a direct target of Gli2, promotes FGFR3 trafficking and cell proliferation in colorectal cancer. Cellular Signalling. 2025. doi:10.1016/j.cellsig.2025.112175
BibTeX
@article{Wang2025,
author = {Wang, Hui and Li, Defu and Yu, Zhengping and Zhang, Jie and Luo, Shiwen and Zhang, Yuanbing},
title = {PDZK1, a direct target of Gli2, promotes FGFR3 trafficking and cell proliferation in colorectal cancer},
journal = {Cellular Signalling},
year = {2025},
doi = {10.1016/j.cellsig.2025.112175}
}
EUVIMED